[PubMed: 40204768] [Free PMC Article] Carvas AO, Leuthardt A, Kulka P, et al
Most GLP-1 side effects are gastrointestinal, mild, and improve within the first few weeks of each dose level Serious warning signs severe abdominal pain, persistent vomiting, or allergic reactions are rare but require immediate medical attention Wegovy, Zepbound, and Foundayo share a similar GI side-effect profile, with some differences in nausea and diarrhea frequency In-person monitoring at PEAK allows your clinician to catch issues early and adjust your titration schedule in real time Starting a GLP-1 medication like Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron) is a major step toward better health and it is completely normal to wonder what to expect along the way
"If you have erectile dysfunction related to poor circulation, Propionyl-L-Carnitine may help boost blood flow and enhance overall sexual function
CONCLUSION By addressing the unique requirements of people using GLP-1s for weight loss, device teams can develop solutions that support better adherence and create a positive, engaging user experience
Qsymia's important trials, CONQUER and SEQUEL, established its efficacy profile over 108 weeks of treatment
